Sylwia Magdalena Kaeding, MD | |
9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 | |
(414) 805-6550 | |
(414) 805-6565 |
Full Name | Sylwia Magdalena Kaeding |
---|---|
Gender | Female |
Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225535354 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 75336-20 (Wisconsin) | Primary |
Entity Name | The Medical College Of Wisconsin Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
Blue Care Network of Michigan's innovative wellness product, Healthy Blue Living, which rewards individuals for committing to healthy lifestyles, reached the 100,000 member benchmark in less than three years.
The U.S. Food and Drug Administration today announced an initiative to reduce unnecessary radiation exposure from three types of medical imaging procedures: computed tomography (CT), nuclear medicine studies, and fluoroscopy.
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
Learning if a lung cancer patient has genetic mutations can help oncologists determine the best approach to treatment. There are four gene mutations (KRAS, TP53, STK11, and EGFR) that most commonly occur in lung cancer; however, there are limited effective therapies to target these mutations. With this in mind, Moffitt Cancer Center performed an extensive genetic analysis of lung cancer specimens to unravel how mutations in the two of those genes (TP53 and STK11) contribute to the biology of lung cancer and patient outcomes.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Sylwia Magdalena Kaeding, MD 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 805-6550 | Sylwia Magdalena Kaeding, MD 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 805-6550 |
News Archive
Blue Care Network of Michigan's innovative wellness product, Healthy Blue Living, which rewards individuals for committing to healthy lifestyles, reached the 100,000 member benchmark in less than three years.
The U.S. Food and Drug Administration today announced an initiative to reduce unnecessary radiation exposure from three types of medical imaging procedures: computed tomography (CT), nuclear medicine studies, and fluoroscopy.
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
Learning if a lung cancer patient has genetic mutations can help oncologists determine the best approach to treatment. There are four gene mutations (KRAS, TP53, STK11, and EGFR) that most commonly occur in lung cancer; however, there are limited effective therapies to target these mutations. With this in mind, Moffitt Cancer Center performed an extensive genetic analysis of lung cancer specimens to unravel how mutations in the two of those genes (TP53 and STK11) contribute to the biology of lung cancer and patient outcomes.
› Verified 3 days ago
Julia Bonner, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3351 North Downer Avenue, Milwaukee, WI 53211 Phone: 414-229-5684 | |
Dr. Zachary Smith, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6830 Fax: 414-955-6214 | |
Dr. Christopher Patrick Boyd, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6000 Fax: 414-805-6280 | |
Umair Bajwa, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812 Fax: 414-805-0855 | |
Dr. Jeffrey Wilson, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, Ste 206, Milwaukee, WI 53233 Phone: 414-219-7136 | |
Rasika Surajyam Chepuri, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-7040 Fax: 414-955-6211 | |
Soryal A Soryal, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, 3rd Floor, Milwaukee, WI 53233 Phone: 414-219-7300 |